The hallmarks of cancer A long non-coding RNA point of view

被引:1601
作者
Gutschner, Tony [1 ]
Diederichs, Sven [2 ]
机构
[1] German Canc Res Ctr, Helmholtz Univ Grp Mol RNA Biol & Canc, Heidelberg, Germany
[2] Heidelberg Univ, Inst Pathol, D-6900 Heidelberg, Germany
关键词
non-coding RNA; ncRNA; lincRNA; gene expression; carcinogenesis; tumor biology; cancer therapy; MALAT1; HOTAIR; XIST; T-UCR; NITRIC-OXIDE SYNTHASE; STEROID-RECEPTOR COACTIVATOR; PROSTATE-SPECIFIC GENE; GROWTH-ARREST; HEPATOCELLULAR-CARCINOMA; WIDE IDENTIFICATION; TELOMERASE ACTIVITY; CELL-PROLIFERATION; ACTIVATOR SRA; UP-REGULATION;
D O I
10.4161/rna.20481
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
With the advent of next generation sequencing methods and progress in transcriptome analysis, it became obvious that the human genome contains much more than just protein-coding genes. In fact, up to 70% of our genome is transcribed into RNA that does not serve as templates for proteins. In this review, we focus on the emerging roles of these long non-coding RNAs (lncRNAs) in the field of tumor biology. Long ncRNAs were found to be deregulated in several human cancers and show tissue-specific expression. Functional studies revealed a broad spectrum of mechanisms applied by lncRNAs such as HOTAIR, MALAT1, ANRIL or lincRNA-p21 to fulfill their functions. Here, we link the cellular processes influenced by long ncRNAs to the hallmarks of cancer and therefore provide an ncRNA point-of-view on tumor biology. This should stimulate new research directions and therapeutic options considering long ncRNAs as novel prognostic markers and therapeutic targets.
引用
收藏
页码:703 / 719
页数:17
相关论文
共 213 条
  • [1] The Bcl-2 apoptotic switch in cancer development and therapy
    Adams, J. M.
    Cory, S.
    [J]. ONCOGENE, 2007, 26 (09) : 1324 - 1337
  • [2] Complex architecture and regulated expression of the Sox2ot locus during vertebrate development
    Amaral, Paulo P.
    Neyt, Christine
    Wilkins, Simon J.
    Askarian-Amiri, Marjan E.
    Sunkin, Susan M.
    Perkins, Andrew C.
    Mattick, John S.
    [J]. RNA, 2009, 15 (11) : 2013 - 2027
  • [3] Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences
    Amit, Doron
    Hochberg, Abraham
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8
  • [4] Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas
    Andersson, S.
    Wallin, K-L
    Hellstroem, A-C
    Morrison, L. E.
    Hjerpe, A.
    Auer, G.
    Ried, T.
    Larsson, C.
    Heselmeyer-Haddad, K.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 95 (03) : 331 - 338
  • [5] [Anonymous], ONCOGENE
  • [6] Cytotoxic Ribonucleases and RNA Interference (RNAi)
    Ardelt, Barbara
    Ardelt, Wojciech
    Darzynkiewicz, Zbigniew
    [J]. CELL CYCLE, 2003, 2 (01) : 22 - 24
  • [7] ARDELT W, 1991, J BIOL CHEM, V266, P245
  • [8] Ribonucleases as potential modalities in anticancer therapy
    Ardelt, Wojciech
    Ardelt, Barbara
    Darzynkiewicz, Zbigniew
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 625 (1-3) : 181 - 189
  • [9] Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system
    Augustin, Hellmut G.
    Koh, Gou Young
    Thurston, Gavin
    Alitalo, Kari
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2009, 10 (03) : 165 - 177
  • [10] Telomeric repeat-containing RNA and RNA surveillance factors at mammalian chromosome ends
    Azzalin, Claus M.
    Reichenbach, Patrick
    Khoriauli, Lela
    Giulotto, Elena
    Lingner, Joachim
    [J]. SCIENCE, 2007, 318 (5851) : 798 - 801